The
research report “Tubeless Insulin Pump
Market Size By Component (Pod/Patch, Remote,
Others), By Distribution Channel (Hospitals, Pharmacies, e-Commerce, Others),
Regional Outlook (U.S., Canada, Germany, UK, Spain, Italy, France, China,
Japan, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi
Arabia), Technology Development, Competitive Landscape & Forecast, 2017 –
2024”
by Global Market Insights, Inc. says, Tubeless Insulin Pump Market size is set
to exceed USD 2 billion by 2024.
Improved
product functionality is a determinant that may incite investors to pour in
their money in tubeless insulin pump industry. Insulet’s latest addition of
smart features to its product is an instance of the aforementioned statement.
Elaborating further, Insulet Corporation, a renowned player across tubeless
insulin pump industry, has recently added additional features such as
touchscreen and Bluetooth to its OmniPod Dash system.
Citing
yet another example, in 2016, Medtrum Technologies Incorporation, a key
participant in tubeless insulin pump market, had launched a tubeless insulin
punch fitted with CGM system. Even Roche Holdings AG, a healthcare firm based
in Switzerland, in 2015, introduced the Accu-Chek Connect – a bolus calculator,
in its tubeless insulin pump, that has apparently helped numerous users to
calculate the proportion of insulin doses to be consumed.
Request for a sample of
this research report - https://www.gminsights.com/request-sample/detail/2032
Critical
agreements between prominent industry giants have ushered in new developments
across tubeless insulin pump industry. Quoting an example, in 2016, Insulet
Corporation and Eli Lilly & Company, a U.S. based pharmaceutical giant, had
signed a pact to build a new type of OmniPod tubeless insulin delivery system
to deliver Lilly’s highly concentrated U200 and U500 insulin formulations. It
is undeniable therefore, that collaborations witnessed across the
pharmaceutical and healthcare industry can have a major impact on the overall
business.
Tubeless
insulin pumps find a remarkably high demand over their tubed counterparts
across the United States. This, as the experts say, is a key determinant that
will facilitate the development of North America tubeless insulin pump market.
In 2016 alone, U.S. tubeless insulin pump industry size was pegged at USD 200
million. The region is expected to make notable contributions toward North
America tubeless insulin pump market share in the ensuing years.
Browse key
industry insights spread across 130 pages with 66 market data tables & 8
figures & charts from this 2017 report Tubeless
Insulin Pump Market in detail along with the table of contents at:
Brazil
tubeless insulin pump market size is slated to expand at a rate of 18% over the
coming timeframe. Easy accessibility of tubeless insulin pumps with
user-friendly features is expected to expand the product penetration in the
region.
Europe
is slated to be one of prime hubs for the development of tubeless insulin pump
market. This prediction may have perhaps stemmed from the fact that the region
is a model instance of highly sophisticated healthcare infrastructure. The
robust improvement in healthcare services in addition to the deployment of
novel technologies across the healthcare sector are projected to have a
significant effect on the growth of Germany tubeless insulin pump market share.
The country is expected to dominate the overall industry share in terms of
revenue over the coming years.
Tubeless
insulin pump industry is projected carve out a profitable growth curve over the
coming years, subject to the product’s innumerable benefits. The market has
been forecast to have bright growth prospects as is evident from the estimates
put forth by a research study – the report apparently states that this market
will grow at a rate of 25% over 2017-2024, having attained USD 350 million in
2016.
Tubeless
insulin pump market is likely to be constrained by a few essential factors,
such as escalating product costs and restricted insurance coverage policies. On
these grounds, manufacturers have been striving to reduce equipment costs and
make them affordable to attract a wider consumer base. In addition, competitive
pricing strategies adopted by the key business players will further help in
reducing the costs of devices, thereby propelling tubeless insulin pump market
expansion.
Browse Related Reports:
Antidiabetics Market Size By
Product (Insulin [Rapid Acting, Long Acting, Premixed, Short Acting,
Intermediate Acting], Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas,
GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolodinediones), By
Application (Type I Diabetes, Type II & Other), Industry Analysis Report,
Regional Outlook, Application Potential, Price Trends, Competitive Market Share
& Forecast, 2016 – 2023
About Global Market Insights:
Global
Market Insights, Inc., headquartered in Delaware, U.S., is a global market
research and consulting service provider; offering syndicated and custom
research reports along with growth consulting services. Our business
intelligence and industry research reports offer clients with penetrative insights
and actionable market data specially designed and presented to aid strategic
decision making. These exhaustive reports are designed via a proprietary
research methodology and are available for key industries such as chemicals,
advanced materials, technology, renewable energy and biotechnology.
Contact
Us:
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter
No comments:
Post a Comment